Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Utah for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Utah only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Utah (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Mitchell Goff (NPI 1578595153)

Field	Value
Entity Type	Individual
Organization	Mitchell Goff
Address	4400 S 700 E Ste 200
City	Salt Lake City
State	UT
ZIP	84107
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	July 6, 2006

Payer Source	Total Paid
Medicare	$3.8M
Medicaid	$0

Key Findings

This profile is overwhelmingly Medicare-driven: lifetime Medicare revenue is $3.8M and there is no Medicaid billing on file, making the provider effectively single-payer in scope for public programs. The precomputed concentration measure shows the top 3 Medicare codes by revenue account for 82.4% of the provider's Medicare take, underlining a focused service mix.

The practice operation is centered on intravitreal drug therapy and related retinal care: J0178 (2.7K claims, $694 avg paid/claim, $1.9M revenue) and J2777 (8.7K claims, $29 avg paid/claim, $252.3K revenue) represent high-volume injection activity, while J3490 (428 claims, $2238 avg paid/claim, $957.9K revenue) captures billed drug or unclassified pharmacy items. This code mix is consistent with a retina specialist whose business model is built on office-based injections and associated drug administration rather than high-volume inpatient surgery.

Revenue is highly concentrated in a few drugs and injection services: J0178 alone accounts for $1.9M (50.2% of Medicare revenue), and together with J3490 and J2777 these three codes make up 82.4% of Medicare revenue. That degree of concentration indicates that changes in drug utilization, reimbursement, or access to specific biologics could materially affect this provider’s revenue stream.

Competitive standing varies by code: for J0178 the provider ranks #240 of 3204 (93th percentile) and is described as "notably above typical national volume," signaling a near-top-tier national position for aflibercept administration. By contrast, J3490 (rank #127 of 2838, 96th percentile) and J2777 (rank #1105 of 2039, 46th percentile) are labeled as "typical, unremarkable volume," indicating that while some drug billing ranks high by count, the plain-English characterization treats those patterns as within expected practice variation.

The practice shows above-typical throughput on both evaluation-and-management and imaging services: 99214 has 923 claims ($85 avg paid/claim, $78.5K revenue) and ranks #13949 of 479517 (97th percentile; described as "notably above typical national volume"), while 92134 has 2.1K claims ($28 avg paid/claim, $59.5K revenue) and also ranks in the 97th percentile with the same "notably above typical national volume" label. These figures point to a steady office visit and retinal imaging volume that supports the high injection caseload.

Surgical retina procedures are present but represent a small share of revenue compared with injections: 67028 (1.9K claims, $91 avg paid/claim, $172.3K revenue) contributes 4.6% of Medicare revenue and ranks #462 of 4255 (89th percentile), while 67041 (20 claims, $874 avg paid/claim, $17.5K revenue) and 67108 (14 claims, $904 avg paid/claim, $12.7K revenue) are low-count, modest contributors. This mix suggests the practice performs some surgical interventions but is primarily an injection- and clinic-based retina service.

The absence of any Medicaid billing on file ("none below") means this provider’s public-payer exposure is concentrated in Medicare only; for payers and network planners that focus on Medicaid populations, this provider is not currently an active in-network contributor based on available claims. That payer concentration increases sensitivity to Medicare policy shifts while limiting direct visibility into the provider’s role in Medicaid-managed care.

The NPI was enumerated on 2006-07-06 (~20 years ago), indicating long tenure in the Medicare program; combined with high-volume J0178 billing and durable imaging/E&M throughput, the data paint a picture of an established retina specialist with a sustained, injection-centric practice model. This longevity supports interpreting current patterns as stable operational behavior rather than a transient billing spike.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

15 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,710	$690	$1.9M
J3490	Unclassified drugs	430	$2,240	$957.9K
J2777	Injection, faricimab‑svoa, 0.1 mg	8,700	$30	$252.3K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,890	$90	$172.3K
J2778	Injection, ranibizumab, 0.1 mg	870	$190	$162.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	920	$90	$78.5K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	330	$220	$72K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,120	$30	$59.5K
Q5124	Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg	250	$170	$43.5K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	200	$110	$22.8K

Showing 1–10 of 15

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Utah Distribution

Mitchell Goff — 4 of 15 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Utah

Full comparison — all codes billed, vs. state median

15 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	4	40	620	$690	$683.2K
J2777	16	20	13,140	$30	$523.9K
J2778	6	10	870	$180	$224.3K
J3490	1	30	80	$1,690	$199.5K
Q5128	2	10	290	$220	$69.1K
67028	5	60	440	$90	$61.7K
Q5124	1	10	250	$170	$43.5K
67041	5	10	20	$1,040	$28.2K
67108	5	10	20	$1,090	$18.6K
99214	46	4,080	80	$80	$11.6K

Showing 1–10 of 15

Related Providers

Other providers that share a Tax Identification Number (TIN) with Mitchell Goff, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nathan Steinle	CA	Retina Specialist (Ophthalmology) Physician	$9.5M	$0
Prema Abraham	SD	Retina Specialist (Ophthalmology) Physician	$7.1M	$0
Kyle Thompson	ID	Retina Specialist (Ophthalmology) Physician	$4.5M	$0
Douglas Holmes	WY	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
David Faber	UT	Retina Specialist (Ophthalmology) Physician	$4M	$0
Richard Kinsey	TN	Anatomic Pathology & Clinical Pathology Physician	$3.3M	$147.3K
Jack Stringham	UT	Retina Specialist (Ophthalmology) Physician	$3.4M	$0
Brendan Girschek	AZ	Ophthalmology Physician	$3.2M	$0
John Bormes	SD	Ophthalmology Physician	$2.6M	$0
John Purviance	WY	Radiation Oncology Physician	$2.5M	$0

Nearby Providers

Other providers in the same ZIP code as Mitchell Goff, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ihc Health Services, Inc.	UT	General Acute Care Hospital	$0	$68.7M
Ihc Health Services, Inc.	UT	Clinical Medical Laboratory	$2.7M	$17.9M
Alpine Home Medical Equipment LLC	UT	Oxygen Equipment & Supplies (DME)	$0	$18.6M
Ddi Vantage	UT	Developmentally Disabled Services Day Training Agency	$0	$18.4M
Utah Emergency Physicians	UT	Emergency Medicine Physician	$0	$14.5M
Home Caregivers Partnership, LLC	UT	Home Health Agency	$0	$10.4M
Gcs Foundation	UT	Supports Brokerage Agency	$0	$6.2M
Ihc Health Services Inc	UT	Diagnostic Radiology Physician	$0	$6.1M
Joel Herring	UT	Retina Specialist (Ophthalmology) Physician	$5.6M	$23.7K
Project Reality	UT	Mental Health Counselor	$0	$5.1M

Mitchell Goff — Billing Profile & Reimbursement Data

Sign up for Mitchell Goff — Billing Profile & Reimbursement Data policy alerts

Mitchell Goff — Billing Profile & Reimbursement Data

Sign up for Mitchell Goff — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References